1260090-16-1

Basic information

• Product Name: 1-(4-((R)-7-allyl-7-methyl-4-((S)-3-methylmorpholino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea
• Synonyms: 1-(4-((R)-7-allyl-7-methyl-4-((S)-3-methylmorpholino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea
• CAS NO: 1260090-16-1
• Molecular Weight: 437.542
• Mol File: 1260090-16-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-(4-((R)-7-allyl-7-methyl-4-((S)-3-methylmorpholino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-((R)-7-allyl-7-methyl-4-((S)-3-methylmorpholino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea(1260090-16-1)
• EPA Substance Registry System: 1-(4-((R)-7-allyl-7-methyl-4-((S)-3-methylmorpholino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea(1260090-16-1)

Safety Data

• Hazardous Substances Data: 1260090-16-1(Hazardous Substances Data)

Upstream product

• 874291-00-6 1-ethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]urea 
• 1293387-83-3 7-allyl-2-chloro-7-methyl-4-((S)-3-methylmorpholino)-5,7-dihydrofuro[3,4-d]pyrimidine 

Relevant articles and documents

OXO-HETEROCYCLE FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR).